Aristides Capital’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-814
Closed -$96K 171
2022
Q1
$96K Hold
814
0.06% 172
2021
Q4
$173K Hold
814
0.08% 216
2021
Q3
$268K Sell
814
-550
-40% -$160K 0.1% 119
2021
Q2
$355K Buy
1,364
+400
+41% +$247K 0.08% 107
2021
Q1
$440K Buy
+964
New +$527K 0.18% 84
2020
Q3
Sell
-850
Closed -$380K 99
2020
Q2
$380K Sell
850
-80
-9% -$32.8K 0.29% 58
2020
Q1
$322K Buy
+930
New +$340K 0.23% 69

Other funds holding CVM

Aristides Capital's CVM Position: Q2 2022 in Review

Aristides Capital sold out of CEL-SCI Corp (CVM) in Q2 2022, closing a stake of 814 shares — an estimated $96K sold.

Aristides Capital first reported a position in CVM in Q1 2020 and held it in 7 quarters. The position peaked at $440K in Q1 2021. 81 funds tracked by Wall St. Rank hold CVM as of Q2 2022.

  • Aristides Capital reported no remaining CEL-SCI Corp position as of Q2 2022 after selling out during the quarter.
  • Aristides Capital sold 814 CEL-SCI Corp shares in Q2 2022, an estimated $96K.
  • Aristides Capital first reported a position in CEL-SCI Corp in Q1 2020 and held it in 7 quarters.
  • Aristides Capital's CEL-SCI Corp position peaked at $440K in Q1 2021.
  • 81 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2022.

Based on Aristides Capital's 13F filing for Q2 2022, filed 15 Aug 2022.